Optune
FDA premarket approval P100034/S030 · decided 2024-01-16
Approval details
- PMA number
- P100034
- Supplement
- S030
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- Optune
- Generic name
- Stimulator, low electric field, tumor treatment
- Applicant
- Novocure, GmbH
- Date received
- 2023-01-25
- Decision date
- 2024-01-16
- Days to decision
- 356 days
- Decision code
- APPR
- Product code
- NZK
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Baar
- Statement
- approval for the MAXPOINT BR-I (MAXPOINT) Optune transducer array layout software
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.